Epigenetic markers and therapeutic targets for metastasis is a research paper published in Cancer and Metastasis Reviews (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: F31 CA261126
NCI NIH HHS
Grant: U01 CA235747
NCI NIH HHS
Grant: P50 CA121974
NCI NIH HHS
Grant: P50 CA196530
NCI NIH HHS
Grant: R01 CA237586
NCI NIH HHS
Grant: R01 CA166376
NCI NIH HHS
Grant: P30 CA016359
National Institutes of Health
Grant: 5F31CA261126-02
Determining the Molecular Contributions of KDM2A in NSCLC Metastasis
National Institutes of Health
Grant: 3P50CA196530-03S1
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma
National Institutes of Health
Grant: 5U01CA235747-05
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.
National Institutes of Health
Grant: 1R01CA166376-01A1
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer
National Institutes of Health
Grant: 1R01CA237586-01A1
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER
National Institutes of Health
Grant: 2P30CA016359-15
COMPREHENSIVE CANCER CENTER
National Institutes of Health
Grant: 2P50CA121974-06A1
The RAC1 Pathway as aTarget for Melanoma Therapy
FWCI
0.73
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals